Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TXNDC9 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
C11orf54 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
SPCS1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
RIF1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
YIPF6 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
TMEM126B - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ARF4 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
CCDC47 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
MMGT1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
MIR636 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ANKRD13C - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
CDS2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
UNC50 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
SSR1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
SYT11 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
PEX2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
BTAF1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
CREG1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
TMCO1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on